Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series

Abstract Background The EyeCee® ONE intraocular lens (Nidek, Gamagori, Japan) has been withdrawn from the market due to a high number of reports of severe ocular hypertension (OHT) following phacoemulsification with implantation of this intraocular lens (IOL). In this case series, we report the resu...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Bastelica, Romain Magny, Joël Poupon, Bertrand Sonigo, Tristan Aubert, Françoise Brignole-Baudouin, Juliette Buffault, Christophe Baudouin, Antoine Labbé
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-024-03810-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846112731643510784
author Paul Bastelica
Romain Magny
Joël Poupon
Bertrand Sonigo
Tristan Aubert
Françoise Brignole-Baudouin
Juliette Buffault
Christophe Baudouin
Antoine Labbé
author_facet Paul Bastelica
Romain Magny
Joël Poupon
Bertrand Sonigo
Tristan Aubert
Françoise Brignole-Baudouin
Juliette Buffault
Christophe Baudouin
Antoine Labbé
author_sort Paul Bastelica
collection DOAJ
description Abstract Background The EyeCee® ONE intraocular lens (Nidek, Gamagori, Japan) has been withdrawn from the market due to a high number of reports of severe ocular hypertension (OHT) following phacoemulsification with implantation of this intraocular lens (IOL). In this case series, we report the results of a toxicological analysis and the surgical management of five patients with severe OHT following the implantation of defective EyeCee® ONE IOLs during cataract surgery. Cases presentation Five patients developed early, severe OHT refractory to maximal medical therapy following uneventful phacoemulsification (PCE) cataract surgery with implantation of an EyeCee® ONE IOL from a defective lot. Glaucoma filtering surgeries were required to control intraocular pressure (IOP). Toxicological analyses were carried out on the aqueous humor of one patient. IOP levels were monitored during postoperative follow-up, but three patients required postoperative adjustments (reintroduction of IOP-lowering therapy, goniopuncture or needling) in order to maintain IOP at satisfactory levels. Toxicological analysis revealed a high concentration of silicon in the aqueous humor of the patient from whom the sample was obtained. Conclusions These cases of OHT following cataract surgery with a defective IOL were of early onset severe, all requiring filtering surgery. The exact mechanism of this OHT has not been determined, but we did find high concentrations of silicon in the aqueous humor of one of these patients. Patients who received EyeCee® ONE IOLs during the same period of time should have their IOP and optic nerve monitored to detect any potential OHT or glaucoma that might appear over time.
format Article
id doaj-art-c014cf39dc064d3d989d014fcba2ec9b
institution Kabale University
issn 1471-2415
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj-art-c014cf39dc064d3d989d014fcba2ec9b2024-12-22T12:22:03ZengBMCBMC Ophthalmology1471-24152024-12-012411510.1186/s12886-024-03810-1Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case seriesPaul Bastelica0Romain Magny1Joël Poupon2Bertrand Sonigo3Tristan Aubert4Françoise Brignole-Baudouin5Juliette Buffault6Christophe Baudouin7Antoine Labbé8Department 3, 15-20 National Vision Hospital, IHU FOReSIGHTToxicology-Biology Department, Saint-Louis - Lariboisière - Fernand Widal GroupToxicology-Biology Department, Saint-Louis - Lariboisière - Fernand Widal GroupSaint Germain Vision Eye CenterDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHTDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHTDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHTDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHTDepartment 3, 15-20 National Vision Hospital, IHU FOReSIGHTAbstract Background The EyeCee® ONE intraocular lens (Nidek, Gamagori, Japan) has been withdrawn from the market due to a high number of reports of severe ocular hypertension (OHT) following phacoemulsification with implantation of this intraocular lens (IOL). In this case series, we report the results of a toxicological analysis and the surgical management of five patients with severe OHT following the implantation of defective EyeCee® ONE IOLs during cataract surgery. Cases presentation Five patients developed early, severe OHT refractory to maximal medical therapy following uneventful phacoemulsification (PCE) cataract surgery with implantation of an EyeCee® ONE IOL from a defective lot. Glaucoma filtering surgeries were required to control intraocular pressure (IOP). Toxicological analyses were carried out on the aqueous humor of one patient. IOP levels were monitored during postoperative follow-up, but three patients required postoperative adjustments (reintroduction of IOP-lowering therapy, goniopuncture or needling) in order to maintain IOP at satisfactory levels. Toxicological analysis revealed a high concentration of silicon in the aqueous humor of the patient from whom the sample was obtained. Conclusions These cases of OHT following cataract surgery with a defective IOL were of early onset severe, all requiring filtering surgery. The exact mechanism of this OHT has not been determined, but we did find high concentrations of silicon in the aqueous humor of one of these patients. Patients who received EyeCee® ONE IOLs during the same period of time should have their IOP and optic nerve monitored to detect any potential OHT or glaucoma that might appear over time.https://doi.org/10.1186/s12886-024-03810-1GlaucomaOcular hypertensionPhacoemulsificationIntraocular lensToxicology
spellingShingle Paul Bastelica
Romain Magny
Joël Poupon
Bertrand Sonigo
Tristan Aubert
Françoise Brignole-Baudouin
Juliette Buffault
Christophe Baudouin
Antoine Labbé
Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series
BMC Ophthalmology
Glaucoma
Ocular hypertension
Phacoemulsification
Intraocular lens
Toxicology
title Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series
title_full Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series
title_fullStr Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series
title_full_unstemmed Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series
title_short Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series
title_sort management and toxicological analysis of ocular hypertension after eyecee r one intraocular lens implantation a case series
topic Glaucoma
Ocular hypertension
Phacoemulsification
Intraocular lens
Toxicology
url https://doi.org/10.1186/s12886-024-03810-1
work_keys_str_mv AT paulbastelica managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT romainmagny managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT joelpoupon managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT bertrandsonigo managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT tristanaubert managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT francoisebrignolebaudouin managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT juliettebuffault managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT christophebaudouin managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries
AT antoinelabbe managementandtoxicologicalanalysisofocularhypertensionaftereyeceeoneintraocularlensimplantationacaseseries